New study aims to boost smart asthma care for children

NCT ID NCT07138027

Recruiting now Knowledge-focused Sponsor: Children's Hospital of Philadelphia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests two strategies to help doctors prescribe SMART therapy—a single inhaler for daily control and quick relief—for children with moderate to severe asthma. Researchers will use electronic reminders and education, plus a community health worker and nurse care manager, to see if these tools increase SMART use. The study involves 18 pediatric clinics and children aged 5-18.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Clinical decision support, education, and population health management
What this could lead to: If successful, this could show effective ways to increase use of SMART therapy in children with asthma, improving symptom control and reducing attacks.
What could go wrong: This is a small, early-stage implementation study with only 18 clinics, so results may not apply broadly. It tests strategies, not a new treatment, so direct patient benefit is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma childhood onset asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA IN CHILDREN

Contacts and locations

Locations

Children's Hospital of Philadelphia
RECRUITING

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.